Pharma Mar SA

09/22/2021 | Press release | Distributed by Public on 09/22/2021 00:40

PharmaMar announces Singapore Health Sciences Authority approval of Zepzelca® (lurbinectedin) for the treatment of metastatic Small Cell Lung Cancer